250 related articles for article (PubMed ID: 23978104)
1. Action and disposition of the β3-agonist nebivolol in the presence of inflammation; an alternative to conventional β1-blockers.
Sanaee F; Jamali F
Curr Pharm Des; 2014; 20(9):1311-7. PubMed ID: 23978104
[TBL] [Abstract][Full Text] [Related]
2. Nebivolol induces, via β3 adrenergic receptor, lipolysis, uncoupling protein 1, and reduction of lipid droplet size in human adipocytes.
Bordicchia M; Pocognoli A; D'Anzeo M; Siquini W; Minardi D; Muzzonigro G; Dessì-Fulgheri P; Sarzani R
J Hypertens; 2014 Feb; 32(2):389-96. PubMed ID: 24256707
[TBL] [Abstract][Full Text] [Related]
3. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
Bundkirchen A; Brixius K; Bölck B; Schwinger RH
J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
[TBL] [Abstract][Full Text] [Related]
4. Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta.
Rozec B; Quang TT; Noireaud J; Gauthier C
Br J Pharmacol; 2006 Apr; 147(7):699-706. PubMed ID: 16474420
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of nebivolol in the rat: low oral absorption, loss in the gut and systemic stereoselectivity.
Sanaee F; Valente Neves D; Lanchote VL; Jamali F
Biopharm Drug Dispos; 2013 Sep; 34(6):312-20. PubMed ID: 23625744
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
Nuttall SL; Routledge HC; Kendall MJ
J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
[TBL] [Abstract][Full Text] [Related]
7. The β-blocker Nebivolol Is a GRK/β-arrestin biased agonist.
Erickson CE; Gul R; Blessing CP; Nguyen J; Liu T; Pulakat L; Bastepe M; Jackson EK; Andresen BT
PLoS One; 2013; 8(8):e71980. PubMed ID: 23977191
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage.
Ozakca I; Arioglu-Inan E; Esfahani H; Altan VM; Balligand JL; Kayki-Mutlu G; Ozcelikay AT
Am J Physiol Heart Circ Physiol; 2013 May; 304(9):H1267-76. PubMed ID: 23457011
[TBL] [Abstract][Full Text] [Related]
9. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.
Dessy C; Saliez J; Ghisdal P; Daneau G; Lobysheva II; Frérart F; Belge C; Jnaoui K; Noirhomme P; Feron O; Balligand JL
Circulation; 2005 Aug; 112(8):1198-205. PubMed ID: 16116070
[TBL] [Abstract][Full Text] [Related]
10. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
[TBL] [Abstract][Full Text] [Related]
11. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
[TBL] [Abstract][Full Text] [Related]
12. Nebivolol protects against myocardial infarction injury via stimulation of beta 3-adrenergic receptors and nitric oxide signaling.
Zhang Z; Ding L; Jin Z; Gao G; Li H; Zhang L; Zhang L; Lu X; Hu L; Lu B; Yu X; Hu T
PLoS One; 2014; 9(5):e98179. PubMed ID: 24849208
[TBL] [Abstract][Full Text] [Related]
13. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of β
Mori A; Sekito A; Sakamoto K; Ishii K; Nakahara T
Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):527-533. PubMed ID: 28160015
[TBL] [Abstract][Full Text] [Related]
15. The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium.
Pott C; Brixius K; Bundkirchen A; Bölck B; Bloch W; Steinritz D; Mehlhorn U; Schwinger RH
Br J Pharmacol; 2003 Feb; 138(3):521-9. PubMed ID: 12569077
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension.
Sander GE; Giles TD
Expert Opin Pharmacother; 2015 Apr; 16(5):763-70. PubMed ID: 25747524
[TBL] [Abstract][Full Text] [Related]
17. Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation.
Aragón JP; Condit ME; Bhushan S; Predmore BL; Patel SS; Grinsfelder DB; Gundewar S; Jha S; Calvert JW; Barouch LA; Lavu M; Wright HM; Lefer DJ
J Am Coll Cardiol; 2011 Dec; 58(25):2683-91. PubMed ID: 22152956
[TBL] [Abstract][Full Text] [Related]
18. Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation.
Maffei A; Di Pardo A; Carangi R; Carullo P; Poulet R; Gentile MT; Vecchione C; Lembo G
Hypertension; 2007 Oct; 50(4):652-6. PubMed ID: 17664392
[TBL] [Abstract][Full Text] [Related]
19. Characterization of beta(1)-selectivity, adrenoceptor-G(s)-protein interaction and inverse agonism of nebivolol in human myocardium.
Maack C; Tyroller S; Schnabel P; Cremers B; Dabew E; Südkamp M; Böhm M
Br J Pharmacol; 2001 Apr; 132(8):1817-26. PubMed ID: 11309254
[TBL] [Abstract][Full Text] [Related]
20. Lack of evidence that nebivolol is a β₃-adrenoceptor agonist.
Frazier EP; Michel-Reher MB; van Loenen P; Sand C; Schneider T; Peters SL; Michel MC
Eur J Pharmacol; 2011 Mar; 654(1):86-91. PubMed ID: 21172342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
